nach oben

European Radiology

Erschienen in:

17.05.2022 | Magnetic Resonance

Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis

verfasst von: Jielin Pan, Wenjuan Li, Lingjing Gu, Chaoran Liu, Ke Zhang, Guobin Hong

Erschienen in: European Radiology | Ausgabe 11/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To determine the performance of diagnostic algorithm of adding hepatobiliary phase (HBP) images in Gd-EOB-DTPA-enhanced MRI for the detection of hepatocellular carcinoma (HCC) measuring up to 3 cm in patients with chronic liver disease.

Methods

We searched multiple databases from inception to April 10, 2020, to identify studies on using Gd-EOB-DTPA-enhanced MRI for the diagnostic accuracy of HCC (≤ 3 cm) in patients with chronic liver disease. The diagnostic algorithm of Gd-EOB-DTPA-enhanced MRI with HBP for HCC was defined as a nodule showing hyperintensity during arterial phase and hypointensity during the portal venous, delayed, or hepatobiliary phases. For gadoxetic acid–enhanced MRI without HBP, the diagnostic criteria were a nodule showing arterial enhancement and hypointensity on the portal venous or delayed phases. The data were extracted to calculate summary estimates of sensitivity, specificity, diagnostic odds ratio, likelihood ratio, and summary receiver operating characteristic (sROC) by using a bivariate random-effects model.

Results

Twenty-nine studies with 2696 HCC lesions were included. Overall Gd-EOB-DTPA-enhanced MRI with HBP had a sensitivity of 87%, specificity of 92%, and the area under the sROC curve of 95%. The summary sensitivity of Gd-EOB-DTPA-enhanced MRI with HBP was significantly higher than that without HBP (84% vs 68%, p = 0.01).

Conclusion

Gd-EOB-DTPA-enhanced MRI with HBP showed higher sensitivity than that without HBP and had comparable specificity for diagnosis of HCC in patients with chronic liver disease.

Key Points

• Hypointensity on HBP is a major feature for diagnosis of HCC.

• Extending washout appearance to the transitional or hepatobiliary phase on Gd-EOB-DTPA provides favorable sensitivity and comparable specificity for diagnosis HCC.

• The summary sensitivity of gadoxetic acid–enhanced MRI with HBP was significantly higher than that without HBP (84% vs 68%, p = 0.01) for diagnosis of HCC in patients with chronic liver disease.

Nur mit Berechtigung zugänglich

Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Dicker D et al (2015) The global burden of cancer 2013. JAMA Oncol 1:505–527CrossRef

Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. The Lancet 379:1245–1255CrossRef

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917CrossRef

Soong RS, Yu MC, Chan KM et al (2011) Analysis of the recurrence risk factors for the patients with hepatocellular carcinoma meeting University of California San Francisco criteria after curative hepatectomy. World J Surg Oncol 9:9CrossRef

Imamura H, Matsuyama Y, Tanaka E et al (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38:200–207CrossRef

Bruix J, Sherman M, American Association for the Study of Liver Disease (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022CrossRef

Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 68:723–750CrossRef

Zech CJ, Bartolozzi C, Bioulac-Sage P et al (2013) Consensus report of the Fifth International Forum for Liver MRI. AJR Am J Roentgenol 201:97–107CrossRef

Forner A, Vilana R, Ayuso C et al (2008) Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 47:97–104CrossRef

10.

Bolondi L, Gaiani S, Celli N et al (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42:27–34CrossRef

11.

Hwang J, Kim YK, Jeong WK, Choi D, Rhim H, Lee WJ (2015) Nonhypervascular hypointense nodules at gadoxetic acid– enhanced Mr imaging in chronic liver disease: diffusion-weighted imaging for characterization. Radiology

12.

Van Beers BE, Pastor CM, Hussain HK (2012) Primovist, Eovist: what to expect? J Hepatol 57:421–429CrossRef

13.

Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE, Choi JY (2010) Added value of gadoxetic acid– enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Radiology 255:459–466

14.

Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma. Part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology 273:30–50CrossRef

15.

Omata M, Cheng AL, Kokudo N et al (2017) Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int 11:317–370CrossRef

16.

Chernyak V, Fowler KJ, Kamaya A et al (2018) Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology 289:816–830CrossRef

17.

Park MJ, Kim YK, Lee MW et al (2012) Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns. Radiology 264:761–770CrossRef

18.

Kim YK, Kim CS, Han YM, Park G (2010) Detection of small hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic resonance imaging replace combining gadopentetate dimeglumine-enhanced and superparamagnetic iron oxide-enhanced magnetic resonance imaging? Invest Radiol 45:740–746CrossRef

19.

Phongkitkarun S, Limsamutpetch K, Tannaphai P, Jatchavala J (2013) Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients. World J Gastroenterol 19:8357–8365CrossRef

20.

Joo I, Lee JM, Lee DH, Jeon JH, Han JK (2019) Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features? Eur Radiol 29:1724–1732CrossRef

21.

Renzulli M, Biselli M, Brocchi S et al (2018) New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm. Gut 67:1674–1682CrossRef

22.

Kim DH, Choi SH, Kim SY, Kim MJ, Lee SS, Byun JH (2019) Gadoxetic acid-enhanced MRI of hepatocellular carcinoma: value of washout in transitional and hepatobiliary phases. Radiology 291:651–657CrossRef

23.

McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Grp P-D (2018) Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies The PRISMA-DTA Statement. JAMA 319:388–396CrossRef

24.

Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–536CrossRef

25.

Higgins J, Green S Cochrane handbook for systematic reviews of interventions of interventions version 5.1.0. The Cochrane Collaboration. http://handbookcochraneorg/chapter_9/9_5_2_identifying_and_measuring_heterogeneityhtm Updated March 2011 Accessed May 28, 2015

26.

Vogelgesang F, Schlattmann P, Dewey M (2018) The evaluation of bivariate mixed models in meta-analyses of diagnostic accuracy studies with SAS, Stata and R. Methods Inf Med 57:111–119CrossRef

27.

Doebler P, Holling H, Bohning D (2012) A mixed model approach to meta-analysis of diagnostic studies with binary test outcome. Psychol Methods 17:418–436CrossRef

28.

Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58:882–893CrossRef

29.

Choi SH, Byun JH, Lim YS et al (2016) Diagnostic criteria for hepatocellular carcinoma ≤ 3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging. J Hepatol 64:1099–1107

30.

Di Pietropaolo M, Briani C, Federici GF et al (2015) Comparison of diffusion-weighted imaging and gadoxetic acid-enhanced MR images in the evaluation of hepatocellular carcinoma and hypovascular hepatocellular nodules. Clin Imaging 39:468–475CrossRef

31.

Zhao XT, Li WX, Chai WM, Chen KM (2014) Detection of small hepatocellular carcinoma using gadoxetic acid-enhanced MRI: Is the addition of diffusion-weighted MRI at 3.0T beneficial? J Dig Dis 15:137–145CrossRef

32.

Park MJ, Kim YK, Lee MH, Lee J (2013) Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (< = 2.0 cm) in patients with hepatitis-induced liver cirrhosis. Acta Radiol 54:127–136

33.

Granito A, Galassi M, Piscaglia F et al (2013) Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study. Aliment Pharmacol Ther 37:355–363CrossRef

34.

Golfieri R, Renzulli M, Lucidi V, Corcioni B, Trevisani F, Bolondi L (2011) Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (< = 2 cm) HCC in cirrhosis. Eur Radiol 21:1233–1242

35.

Paisant A, Vilgrain V, Riou J et al (2020) Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCs. J Hepatol 72:937–945CrossRef

36.

Zhou Y, Jing X, Zhang X et al (2019) Combining the arterial phase of contrast-enhanced ultrasonography, gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging in the diagnosis of hepatic nodules ≤ 20 mm in patients with cirrhosis. Ultrasound Med Biol 45:693–701

37.

Joo I, Lee JM, Lee DH, Jeon JH, Han JK, Choi BI (2015) Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout? Eur Radiol 25:2859–2868CrossRef

38.

Kim YK, Kim YK, Park HJ, Park MJ, Lee WJ, Choi D (2014) Noncontrast MRI with diffusion-weighted imaging as the sole imaging modality for detecting liver malignancy in patients with high risk for hepatocellular carcinoma. Magn Reson Imaging 32:610–618CrossRef

39.

Kim MY, Kim YK, Park HJ, Park MJ, Lee WJ, Choi D (2014) Diagnosis of focal liver lesions with gadoxetic acid-enhanced MRI: is a shortened delay time possible by adding diffusion-weighted imaging? J Magnc Reson Imaging 39:31–41CrossRef

40.

Hwang J, Kim YK, Kim JM, Lee WJ, Choi D, Hong SS (2014) Pretransplant diagnosis of hepatocellular carcinoma by gadoxetic acid-enhanced and diffusion-weighted magnetic resonance imaging. Liver Transpl 20:1436–1446

41.

Kim YK, Kim CS, Han YM, Lee YH (2011) Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial? Clin Radiol 66:489–496CrossRef

42.

Chou CT, Chen YL, Su WW, Wu HK, Chen RC (2010) Characterization of cirrhotic nodules with gadoxetic acid-enhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging. J Magnc Reson Imaging 32:895–902CrossRef

43.

Choi MH, Choi JI, Lee YJ, Park MY, Rha SE, Lall C (2017) MRI of small hepatocellular carcinoma: typical features are less frequent below a size cutoff of 1.5 cm. AJR Am J Roentgenol 208:544–551CrossRef

44.

Yu MH, Kim JH, Yoon JH et al (2014) Small (< = 1-cm) Hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging. Radiology 271:748–760

45.

Park VY, Choi JY, Chung YE et al (2014) Dynamic enhancement pattern of HCC smaller than 3 cm in diameter on gadoxetic acid-enhanced MRI: comparison with multiphasic MDCT. Liver Int 34:1593–1602CrossRef

46.

Ooka Y, Kanai F, Okabe S et al (2013) Gadoxetic acid-enhanced MRI compared with CT during angiography in the diagnosis of hepatocellular carcinoma. Magn Reson Imaging 31:748–754CrossRef

47.

Choi JW, Lee JM, Kim SJ et al (2013) Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR images and their value as an imaging biomarker. Radiology 267:776–786CrossRef

48.

Rhee H, Kim MJ, Park YN, Choi JS, Kim KS (2012) Gadoxetic acid-enhanced MRI findings of early hepatocellular carcinoma as defined by new histologic criteria. J Magnc Reson Imaging 35:393–398CrossRef

49.

Rhee H, Kim MJ, Park MS, Kim KA (2012) Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI. Br J Radiol 85:e837–e844CrossRef

50.

Kim AY, Kim YK, Lee MW et al (2012) Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis. Acta Radiol 53:830–838CrossRef

51.

Kim YK, Kim CS, Han YM, Yu HC, Choi D (2011) Detection of small hepatocellular carcinoma: intraindividual comparison of gadoxetic acid-enhanced MRI at 3.0 and 1.5 T. Invest Radiol 46:383–389CrossRef

52.

Kawada N, Ohkawa K, Tanaka S et al (2010) Improved diagnosis of well-differentiated hepatocellular carcinoma with gadolinium ethoxybenzyl diethylene triamine pentaacetic acid-enhanced magnetic resonance imaging and Sonazoid contrast-enhanced ultrasonography. Hepatol Res 40:930–936CrossRef

53.

Di Martino M, Marin D, Guerrisi A et al (2010) Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the detection of hepatocellular carcinoma in patients with cirrhosis. Radiology 256:806–816CrossRef

54.

Kierans AS, Kang SK, Rosenkrantz AB (2016) The diagnostic performance of dynamic contrast-enhanced MR imaging for detection of small hepatocellular carcinoma measuring up to 2 cm: a meta-analysis. Radiology 278:82–94CrossRef

55.

Lee YJ, Lee JM, Lee JS et al (2015) Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis. Radiology 275:97–109CrossRef

56.

Mazzaferro V, Llovet JM, Miceli R et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35–43CrossRef

57.

Bashir MR, Gupta RT, Davenport MS et al (2013) Hepatocellular carcinoma in a North American population: does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis? J Magn Reson Imaging 37:398–406CrossRef

58.

Palmucci S (2014) Focal liver lesions detection and characterization: the advantages of gadoxetic acid-enhanced liver MRI. World J Hepatol 6:477–485CrossRef

59.

Deeks JJ (2001) Systematic reviews in health care - systematic reviews of evaluations of diagnostic and screening. BMJ 323:157–162CrossRef

60.

Gregoire G, Derderian F, Le Lorier J (1995) Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias? J Clin Epidemiol 48:159–163CrossRef

Titel: Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis
verfasst von: Jielin Pan
Wenjuan Li
Lingjing Gu
Chaoran Liu
Ke Zhang
Guobin Hong
Publikationsdatum: 17.05.2022
Verlag: Springer Berlin Heidelberg
Erschienen in: European Radiology / Ausgabe 11/2022
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-022-08826-z

Neu im Fachgebiet Radiologie

08.04.2024 | Andrologie | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis

Abstract

Objectives

Methods

Results

Conclusion

Key Points

Neu im Fachgebiet Radiologie

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Quantitative Angiografie könnte IVUS-Alternative darstellen

Die Ganz-Genom-Sequenzierung startet

Update Radiologie

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusion

Key Points

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2022

3-T MR neurography of lumbo-sacral plexus in hereditary transthyretin-related amyloidosis with polyneuropathy

Forensic age assessment by 3.0 T MRI of the wrist: adaption of the Vieth classification

Radiology artificial intelligence: a systematic review and evaluation of methods (RAISE)

Prognostic value of quantitative cervical nodal necrosis burden on MRI in nasopharyngeal carcinoma and its role as a stratification marker for induction chemotherapy

Ultrasound high-definition microvasculature imaging with novel quantitative biomarkers improves breast cancer detection accuracy

Comparison of diagnostic accuracy and utility of artificial intelligence–optimized ACR TI-RADS and original ACR TI-RADS: a multi-center validation study based on 2061 thyroid nodules

Neu im Fachgebiet Radiologie

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Quantitative Angiografie könnte IVUS-Alternative darstellen

Die Ganz-Genom-Sequenzierung startet

Update Radiologie